Hand sanitizers and surface disinfectants have proven essential in the COVID-19 era but are also a critical means to reduce or prevent the spread of many infectious diseases. This is one of the reasons the Department of Homeland Security (DHS) is investing in a potentially fast, effective, and longer-lasting alternative to alcohol-based solutions. The DHS Science and Technology Directorate’s (S&T) Silicon Valley Innovation Program (SVIP) has awarded $105,877 in Phase 1 funding for Bloodstone Division, LLC’s development of an anti-viral disinfectant under the SVIP Emerging Needs: COVID-19 Response & Future Mitigation solicitation. Learn more via the URL shown in the “Website Address” box above…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; AmacFoundation.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc. or the AMAC Foundation, Inc.